TapImmune to Host Inaugural Quarterly Business Update Conference Call and Webcast


Company to Provide Corporate and Clinical Overview on Tuesday, March 14, 2017, 4:30pm ET

[/vc_column_text][vc_empty_space height=”8px”][vc_column_text]JACKSONVILLE, FLORIDA – March 8, 2017 – TapImmune, Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics for the treatment of cancer and metastatic disease, today announced that the Company will host a conference call and live audio webcast on Tuesday, March 14, 2017, at 4:30 p.m. ET, to provide a corporate and clinical update for the fourth quarter and year end 2016.

Reserve Your Seat: Register Today

The event will be webcast live via the Internet on:

March 14, 2017

4:30 PM ET

Click here to register today, or visit https://www.markertherapeutics.com/register/.

Day-of Call-in Information:

To access the live conference call on March 14, 2017, at 4:30pm ET you may use:

  • (877) 870-4263 (U.S.)
  • (412) 317-0790 (International)

To access the live audio webcast, visit the Events section of the TapImmune website https://www.markertherapeutics.com/events/. The webcast will also be archived for 90 days beginning at approximately 6:30 p.m. ET, on March 14, 2017.[/vc_column_text][vc_empty_space][vc_column_text][pr-disclaimer]